Product Information

ICOSAPENT ETHYL 0.5 GM CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.3483 per EA under NDC 00054062127. Its NADAC has been published 165 times since Sep 20, 2023.

FDA first approved this application on May 21, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ICOSAPENT ETHYL 0.5 GM CAPSULE

Icosapent Ethyl
$0.3483per EA

Strength

.5 g/1

NDC

00054062127

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ICOSAPENT ETHYL

Approval Type

Generic (ANDA)

FDA Application

ANDA209457

FDA Approved

5/21/2020

TE Code

AB

On Market Since

11/4/2020

Price Statistics

The NADAC for ICOSAPENT ETHYL 0.5 GM CAPSULE has been published 165 times since Sep 20, 2023, and over the history we have for it it has declined 67.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3483 per EA
All-time high$1.0599 (Apr 10, 2024)
All-time low$0.3208 (Feb 18, 2026)
52-week high$0.4706
52-week low$0.3208
Median price$0.5797
Average price$0.6305
Largest weekly change-24.1% (Nov 20, 2024)
Weeks tracked165
Tracking sinceSep 20, 2023

Price History

1W

0.0%

1M

+4.2%

3M

+5.1%

6M

-4.3%

1Y

-32.5%

3Y

-67.1%

5Y

N/A

All

-67.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Icosapent Ethyl market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ICOSAPENT ETHYL 0.5 GM CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ICOSAPENT ETHYL 0.5 GM CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $0.3483 per EA (NDC 00054062127), effective Nov 11, 2026.

How has the price of ICOSAPENT ETHYL 0.5 GM CAPSULE changed over time?

Over the history we have for it, the NADAC for ICOSAPENT ETHYL 0.5 GM CAPSULE has declined 67.1%. It has been tracked across 165 weekly CMS publications since Sep 20, 2023.

What are the highest and lowest recorded NADAC prices for ICOSAPENT ETHYL 0.5 GM CAPSULE?

Since Sep 20, 2023, the NADAC for ICOSAPENT ETHYL 0.5 GM CAPSULE has ranged from a low of $0.3208 (Feb 18, 2026) to a high of $1.0599 (Apr 10, 2024), with a median of $0.5797 per EA.

Are there cheaper alternatives to ICOSAPENT ETHYL 0.5 GM CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of ICOSAPENT ETHYL 0.5 GM CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ICOSAPENT ETHYL 0.5 GM CAPSULE?

ICOSAPENT ETHYL 0.5 GM CAPSULE (NDC 00054062127) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.